How to improve morbidity and mortality in systemic lupus erythematosus

Rheumatology (Oxford). 2000 Mar;39(3):238-44. doi: 10.1093/rheumatology/39.3.238.

Authors

M B Urowitz¹, D D Gladman

Affiliation

¹ University of Toronto Lupus Clinic and Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.

PMID: 10788530
DOI: 10.1093/rheumatology/39.3.238

No abstract available

Publication types

Review

MeSH terms

Arteriosclerosis / etiology
Bone Diseases / etiology
Cognition Disorders / etiology
Fatigue / etiology
Female
Humans
Lupus Erythematosus, Systemic / complications
Lupus Erythematosus, Systemic / mortality*
Morbidity / trends
Survival Rate / trends